Literature DB >> 12660677

Troponin I elevation and cardiac events after percutaneous coronary intervention.

Mark J Ricciardi1, Charles J Davidson, George Gubernikoff, Nirat Beohar, Lorene J Eckman, Michele A Parker, Robert O Bonow.   

Abstract

BACKGROUND: Serum troponins are sensitive markers of myonecrosis and ischemia and are now widely used in clinical practice. Although percutaneous coronary intervention (PCI)-related creatine kinase-myocardial band isoenzyme (CK-MB) elevation has been associated with future cardiac events, the significance of troponin elevation in this setting is unknown. We sought to determine whether serum troponin I (Tn-I) elevation after PCI is associated with future cardiac events. Methods and Results Consecutive patients undergoing elective PCI underwent systematic postprocedure measurement of Tn-I and CK-MB levels. Serum levels were correlated with demographic, angiographic, and procedural characteristics and the development of major adverse cardiac events (MACE; defined as death, MI, or need for PCI or coronary bypass graft surgery) at 30 days, 6 months, and 1 year. In 286 consecutive procedures, postintervention myonecrosis-specific Tn-I was elevated in 13.6% of patients, and CK-MB was elevated in 12.9% of patients. Multivariable predictors of Tn-I elevation were procedural side branch occlusion and thrombus formation. Peak Tn-I and CK-MB values were well correlated (r = 0.81, P <.0001). Three-fold elevation of Tn-I after successful PCI was independently predictive of MACE (P =.01).
CONCLUSIONS: Tn-I elevation after elective PCI is relatively common and is associated with procedural complications such as incidental side branch occlusion and thrombus formation. In addition, this study demonstrates that a 3-fold elevation of Tn-I after successful elective PCI is predictive of future cardiac events, especially the need for early repeat revascularization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12660677     DOI: 10.1067/mhj.2003.2

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  15 in total

1.  Frequency, risk factors, and effect on long-term survival of increased troponin I following uncomplicated elective percutaneous coronary intervention.

Authors:  Henry S Loeb; Jayson C Liu
Journal:  Clin Cardiol       Date:  2010-12       Impact factor: 2.882

Review 2.  Differential diagnosis of elevated troponins.

Authors:  Susanne Korff; Hugo A Katus; Evangelos Giannitsis
Journal:  Heart       Date:  2006-07       Impact factor: 5.994

3.  The assessment of Shin's method for the prediction of creatinine kinase-MB elevation after percutaneous coronary intervention: an intravascular ultrasound study.

Authors:  Eun-Seok Shin; Hector M Garcia-Garcia; Scot Garg; Jongha Park; Shin-Jae Kim; Patrick W Serruys
Journal:  Int J Cardiovasc Imaging       Date:  2010-10-24       Impact factor: 2.357

4.  Contrast-enhanced cardiovascular magnetic resonance in the hyperacute phase of ST-elevation myocardial infarction.

Authors:  Eric Larose; Julie Côté; Josep Rodés-Cabau; Bernard Noël; Gerald Barbeau; Edith Bordeleau; Santiago Miró; Bernard Brochu; Robert Delarochellière; Olivier F Bertrand
Journal:  Int J Cardiovasc Imaging       Date:  2009-03-15       Impact factor: 2.357

5.  Elective percutaneous coronary intervention: the relationship between preprocedural blood glucose levels and periprocedural myocardial injury.

Authors:  Mohsen Madani; Keivan Alizadeh; Sepideh Parchami Ghazaee; Abbas Zavarehee; Seifollah Abdi; Farshad Shakerian; Negar Salehi; Ata Firouzi
Journal:  Tex Heart Inst J       Date:  2013

6.  Early invasive strategy and outcomes of non-ST-elevation acute coronary syndrome patients: is time really the major determinant?

Authors:  Cristina Giglioli; Emanuele Cecchi; Daniele Landi; Serafina Valente; Marco Chiostri; Salvatore Mario Romano; Valentina Spini; Laura Perrotta; Ignazio Simonetti; Gian Franco Gensini
Journal:  Intern Emerg Med       Date:  2011-06-07       Impact factor: 3.397

Review 7.  Myocardial ischemia is a key factor in the management of stable coronary artery disease.

Authors:  Kohichiro Iwasaki
Journal:  World J Cardiol       Date:  2014-04-26

8.  Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease.

Authors:  T Nageh; R A Sherwood; B M Harris; M R Thomas
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

9.  Safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention.

Authors:  José G Díez; Hector M Medina; Benjamin Y C Cheong; Lawrence O'Meallie; James J Ferguson
Journal:  Tex Heart Inst J       Date:  2009

10.  Sensory-sympathetic coupling in superior cervical ganglia after myocardial ischemic injury facilitates sympathoexcitatory action via P2X7 receptor.

Authors:  Jun Liu; Guilin Li; Haiying Peng; Guihua Tu; Fanjun Kong; Shuangmei Liu; Yun Gao; Hong Xu; Shuyi Qiu; Bo Fan; Qicheng Zhu; Shicheng Yu; Chaoran Zheng; Bing Wu; Lichao Peng; Miaomiao Song; Qin Wu; Guodong Li; Shangdong Liang
Journal:  Purinergic Signal       Date:  2013-06-11       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.